missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human Matrilin-3 ELISA Kit
ELISA
$890.00 - $4,420.00
Spécifications
| Accession Number | AV009181; B14.5 b; CI-B14.5 b; DIPOA; EDM5; HOA; Matn3; matrilin 3; matrilin-3; NADHDH2; NDUFC2; OADIP; OS2 |
|---|---|
| Assay Range | 20 to 5,000 pg/mL |
| Assay Sensitivity | 20 pg/mL |
| Conjugate | HRP |
| Product Type | ELISA |
| Numéro de catalogue | Numéro du manufacturier. | Quantity | Prix | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Numéro de catalogue | Numéro du manufacturier. | Quantity | Prix | Quantity & Availability | |||||
EH314RBX5
|
Invitrogen™
EH314RBX5 |
5 x 96 Tests |
chaque for $4,420.00
|
|
Connectez-vous ou enregistrez-vous pour vérifier votre prix et la disponibilité.
|
||||
|
EH314RB
|
Invitrogen™
EH314RB |
96 Tests |
chaque for $890.00
|
|
Connectez-vous ou enregistrez-vous pour vérifier votre prix et la disponibilité.
|
||||
Description
Human Matrilin-3 quantitates human Matrilin-3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Matrilin-3.
Matrilins (MATNs) are a family of non-collagenous extra-cellular matrix (ECM) proteins consisting of four known members that have been proposed to play key roles in modulating cellular phenotypes during chondrogenesis of mesenchymal stem cells (MSCs). MATN1 and MATN3 are expressed specifically in cartilage and are among the most up-regulated ECM proteins during chondrogenesis. MATN3 is composed of a single N-terminal von Willebrand Factor A (vWFA) domain followed by four epidermal growth factor (EGF) repeats and a coiled-coil domain whereas MATN1 is composed of two vWFA domains separated by one EGF-like domain. MATN1 or MATN3 may play a role in modulating chondrogenesis during the chondrocyte differentiation process. Mutations of this gene have been associated with variety of inherited chondrodysplasias. Recent studies show that aberrant expression and processing of MATN3 are hallmarks of conventional cartilaginous neoplasms.Spécifications
| AV009181; B14.5 b; CI-B14.5 b; DIPOA; EDM5; HOA; Matn3; matrilin 3; matrilin-3; NADHDH2; NDUFC2; OADIP; OS2 | |
| 20 pg/mL | |
| ELISA | |
| Colorimetric Microplate Reader | |
| MATN3 | |
| <10 | |
| HRP | |
| Plasma 50 μL, Serum 50 μL, Supernatant 50 μL | |
| Matrilin 3 | |
| 4 hrs 45 mins |
| 20 to 5,000 pg/mL | |
| HRP | |
| Plasma, Serum, Supernatant | |
| 4148 | |
| <12% | |
| Pre-coated 96 well plate, Standard, Assay Diluent concentrate, Biotinylated Detection Antibody, SAV-HRP, Wash Buffer, Chromogen, Stop Solution, Adhesive Plate Covers | |
| RUO | |
| 2°C to 8°C | |
| 1 hrs 20 mins |